Frequently reactive and chemically unstable, epoxide metabolites, formed primarily via the action of the cytochrome P450 monooxygenases, have been identified as ultimate carcinogenic and cytotoxic reaction products. Ultimately, the overall balance between bioactivation and detoxication pathways will determine the kinetics and fate of reactive intermediates within target cells. It appears likely that interindividual and tissue differences in susceptibility to toxic sequelae (such as cancers and certain birth defects) may be associated with an altered predisposition to detoxify epoxides. Although the cell has developed the capacity to metabolize epoxides through several pathways, e.g., via the glutathione S-transferases, the focus of this research program is to identify and characterize molecular aspects regulating the expression of a key enzyme involved in epoxide disposition, microsomal epoxide hydrolase (mEH). The mEH enzyme (EC 3.3.2.3) catalyzes the trans-addition of water to a broad range of epoxides and arene oxides, including oxides of the carcinogenic polyaromatic hydrocarbons. Our CENTRAL HYPOTHESIS is that altered expression and genetic variation within the mEH gene locus is a contributing factor toward differential cell and tissue susceptibility and individual risk of toxicity from chemical exposures. To test this hypothesis, two major specific aims are proposed. The first is to determine the mechanisms of post-transcriptional regulation of wild type and genetically variant mEH gene products in stably transfected cell lines representing various tissue origins. The second is to characterize the structural details of alternative mEH gene promoters with respect to DNA sequence composition, cell and tissue usage and interaction with nuclear regulatory proteins. Through analysis of the details that regulate expression of human mEH, genetic diversity among these pathways, and functional effects of altered mEH profiles within the cell, we hope to eventually develop biomonitoring, diagnostic, and perhaps, therapeutic approaches that will enable effective identification and intervention strategies for individuals at risk for toxic outcomes subsequent to toxic chemical exposures.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES004978-11
Application #
6342559
Study Section
Special Emphasis Panel (ZRG4-ALTX-1 (01))
Program Officer
Thompson, Claudia L
Project Start
1989-01-01
Project End
2002-12-31
Budget Start
2001-01-01
Budget End
2001-12-31
Support Year
11
Fiscal Year
2001
Total Cost
$215,328
Indirect Cost
Name
University of Washington
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Liang, Shun-Hsin; Hassett, Christopher; Omiecinski, Curtis J (2005) Alternative promoters determine tissue-specific expression profiles of the human microsomal epoxide hydrolase gene (EPHX1). Mol Pharmacol 67:220-30
Abdel-Rahman, Sherif Z; Ammenheuser, Marinel M; Omiecinski, Curtis J et al. (2005) Variability in human sensitivity to 1,3-butadiene: influence of polymorphisms in the 5'-flanking region of the microsomal epoxide hydrolase gene (EPHX1). Toxicol Sci 85:624-31
Hosagrahara, Vinayak P; Rettie, Allan E; Hassett, Christopher et al. (2004) Functional analysis of human microsomal epoxide hydrolase genetic variants. Chem Biol Interact 150:149-59
Prozialeck, Walter C; Grunwald, Gerald B; Dey, P Markus et al. (2002) Cadherins and NCAM as potential targets in metal toxicity. Toxicol Appl Pharmacol 182:255-65
Farin, F M; Janssen, P; Quigley, S et al. (2001) Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson's disease. Pharmacogenetics 11:703-8
Omiecinski, C J; Hassett, C; Hosagrahara, V (2000) Epoxide hydrolase--polymorphism and role in toxicology. Toxicol Lett 112-113:365-70
Fretland, A J; Omiecinski, C J (2000) Epoxide hydrolases: biochemistry and molecular biology. Chem Biol Interact 129:41-59
Sandberg, M; Hassett, C; Adman, E T et al. (2000) Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms. J Biol Chem 275:28873-81
Raaka, S; Hassett, C; Omiencinski, C J (1998) Human microsomal epoxide hydrolase: 5'-flanking region genetic polymorphisms. Carcinogenesis 19:387-93
Hassett, C; Laurenzana, E M; Sidhu, J S et al. (1998) Effects of chemical inducers on human microsomal epoxide hydrolase in primary hepatocyte cultures. Biochem Pharmacol 55:1059-69

Showing the most recent 10 out of 24 publications